KFF Tracking Poll on Health Information and Trust: January 2025

As Senate hearings begin for President Trump’s health nominees, including Robert F. Kennedy Jr., the latest KFF Tracking Poll on Health Information and Trust shows a decline in public trust for government health agencies like the CDC, FDA, and local public health officials. The poll reveals growing skepticism about vaccines and school vaccine requirements, especially…

Read More

This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’

Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnology with electronics comes with on-board sensors that enable clinicians to monitor and control an implant’s drug production process. The post This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’ appeared first…

Read More

With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and PBMs

Eli Lilly now offers vials of obesity medication Zepbound directly to self-pay patients at a nearly 50% discount off the drug’s list price. But more than offering patients a lower-cost alternative, this move represents a strategic stance against certain pharmaceutical industry players. The post With Direct-to-Patient Zepbound, Eli Lilly Takes a Stand Against Compounders and…

Read More